Recently, 108 genomic loci were identified by SNP meta-analysis as conferring significant risk for SCZ, and MEF2C was identified as a candidate risk gene (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). This evidence concerns the gene MEF2C and schizophrenia.